These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 27354616

  • 21. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S, Bhatt VR, Verma V, Pathak R, Bociek RG, Vose JM, Armitage JO.
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [Abstract] [Full Text] [Related]

  • 22. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF.
    Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
    [Abstract] [Full Text] [Related]

  • 23. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.
    Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA.
    Cancer; 2014 Sep 01; 120(17):2735-41. PubMed ID: 24842808
    [Abstract] [Full Text] [Related]

  • 24. Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.
    Dadey DYA, Medress ZA, Sharma M, Ugiliweneza B, Wang D, Rodrigues A, Parker J, Burton E, Williams B, Han SS, Boakye M, Skirboll S.
    J Neurooncol; 2023 Sep 01; 164(3):655-662. PubMed ID: 37792220
    [Abstract] [Full Text] [Related]

  • 25. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X, Wang X, Wei L, Liu J, Chen M.
    Curr Probl Cancer; 2020 Dec 01; 44(6):100613. PubMed ID: 32563531
    [Abstract] [Full Text] [Related]

  • 26. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
    Jiang S, Zhen H, Jiang H.
    Curr Probl Cancer; 2020 Feb 01; 44(1):100502. PubMed ID: 31537411
    [Abstract] [Full Text] [Related]

  • 27. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z, Liu L, Leng K, Shi G.
    J Gastroenterol Hepatol; 2023 Sep 01; 38(9):1474-1484. PubMed ID: 37114675
    [Abstract] [Full Text] [Related]

  • 28. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D, Hebert B, Potti A.
    Anticancer Res; 2002 Sep 01; 22(6B):3797-9. PubMed ID: 12552996
    [Abstract] [Full Text] [Related]

  • 29. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X, Jin Y, Chen Y, Jiang Z, Liu Z, Zhao Z, Yan P, Wang G, Wang X.
    PLoS One; 2015 Sep 01; 10(11):e0143067. PubMed ID: 26571301
    [Abstract] [Full Text] [Related]

  • 30. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
    Anderson JK, Alanee S, Lindgren B, Slaton J.
    Urol Oncol; 2013 Aug 01; 31(6):862-5. PubMed ID: 21784673
    [Abstract] [Full Text] [Related]

  • 31. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
    Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.
    Cancer; 2015 Jan 15; 121(2):259-68. PubMed ID: 25223713
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Bian X, He X, Yang L, Wu W, Li L.
    Dig Dis Sci; 2020 Jul 15; 65(7):2140-2147. PubMed ID: 31673904
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Risk of second primary malignancy after nasopharyngeal carcinoma in the United States: A population-based study.
    Chan JY, Gooi Z, Mydlarz WK, Agrawal N.
    Head Neck; 2016 Apr 15; 38 Suppl 1():E1130-6. PubMed ID: 26314805
    [Abstract] [Full Text] [Related]

  • 38. Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.
    Ye X, Tan Y, Ma R, Lou P, Yuan Y.
    Medicina (Kaunas); 2023 Aug 15; 59(8):. PubMed ID: 37629753
    [Abstract] [Full Text] [Related]

  • 39. Impact of liver transplantation on the risk of second malignant tumors among hepatocellular carcinoma patients.
    Oweira H, Schmidt J, Helbling D, Petrausch U, Schöb O, Mehrabi A, Giryes A, Elhadedy H, Abdel-Rahman O.
    Expert Rev Gastroenterol Hepatol; 2017 Sep 15; 11(9):865-869. PubMed ID: 28697656
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.